organization · Reporting owner

ADAMS STREET PARTNERS LLC

Disclosed activity across 6 companies

Tapewire entity: 78834
SEC CIK: 0001193586

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Aptinyx Inc.APTX · Entity 120922	10% owner	September 30, 2020	October 02, 2020
Corvus Pharmaceuticals, Inc.CRVS · Entity 4839	10% owner	August 11, 2022	August 15, 2022
Q2 Holdings, Inc.QTWO · Entity 4051	10% owner	May 24, 2017	May 26, 2017
Rimini Street, Inc.RMNI · Entity 5475	10% owner	June 03, 2025	June 05, 2025

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Aptinyx Inc.

Report date September 30, 2020 · Filed October 02, 2020

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.38 · Expires 2030-09-29	IndirectSee Footnote	4,623	Reported balance After 2020-09-30 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2020-09-30 · Grant · Acquired 4,623 · Balance 4,623 F1: The option award was issued to Elisha P. ("Terry") Gould III, who elected to take equity awards in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant. F2: This option is fully vested at time of grant. F3: Elisha P. Gould III is a partner of Adams Street Partners, LLC ("Adams Street"). Adams Street is the direct or indirect general partner/investment adviser of managed entities that own common stock of the Issuer. By agreement with certain of such Adams Street funds, Mr. Gould is deemed to hold the stock options for the benefit of those funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin Murray and Fred Wang, each of whom is a partner of Adams Street (or a subsidiary thereof) may be deemed to have shared voting and investment power over the options. Adams Street and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin Murray and Fred Wang disclaim beneficial ownership of the options except to the extent of their pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: The option award was issued to Elisha P. ("Terry") Gould III, who elected to take equity awards in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.

F2: This option is fully vested at time of grant.

F3: Elisha P. Gould III is a partner of Adams Street Partners, LLC ("Adams Street"). Adams Street is the direct or indirect general partner/investment adviser of managed entities that own common stock of the Issuer. By agreement with certain of such Adams Street funds, Mr. Gould is deemed to hold the stock options for the benefit of those funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin Murray and Fred Wang, each of whom is a partner of Adams Street (or a subsidiary thereof) may be deemed to have shared voting and investment power over the options. Adams Street and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin Murray and Fred Wang disclaim beneficial ownership of the options except to the extent of their pecuniary interest therein.

Corvus Pharmaceuticals, Inc.

Report date August 11, 2022 · Filed August 15, 2022

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.97 · Expires 2032-08-11	IndirectSee Footnote	15,000	Reported balance After 2022-08-11 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2022-08-11 · Grant · Acquired 15,000 · Balance 15,000 F3: The underlying shares subject to the option vest and become exercisable as to one-twelfth (1/12th) of the shares subject to the option in successive, equal monthly installments measured from August 11, 2022, subject to Elisha P. Gould's continued service relationship with the Issuer on each such vesting date. F4: This option was granted to Elisha P. Gould, a director of Corvus Pharmaceuticals, Inc., who is a partner of Adams Street Partners, LLC. Adams Street Partners, LLC is the managing member of the general partner of the general partner of each of the Funds. By agreement with the Funds, Mr. Gould is deemed to hold the option for the benefit of the Funds. The option may be deemed to be indirectly beneficially owned by Adams Street Partners, LLC. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), disclaim beneficial ownership of the option except to the extent of the pecuniary interest therein.
Common Stock, $0.0001 par valueSEC Table I · non-derivative	IndirectBy Funds	3,275,616	Reported balance Holding disclosure · report date 2022-08-11 · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · Balance 3,275,616 F1: Represents 694,854 shares held by Adams Street 2011 Direct Fund LP ("AS 2011"), 715,361 shares held by Adams Street 2012 Direct Fund LP ("AS 2012"), 541,133 shares held by Adams Street 2013 Direct Fund LP ("AS 2013"), 736,033 shares held by Adams Street 2014 Direct Fund LP ("AS 2014"), 69,864 shares held by Adams Street 2015 Direct Venture/Growth Fund LP ("AS 2015"), 67,769 shares held by Adams Street 2016 Direct Venture/Growth Fund LP ("AS 2016"), 87,668 shares held by Adams Street 2017 Direct Venture/Growth Fund LP ("AS 2017"), 126,806 shares held by Adams Street 2018 Direct Venture/Growth Fund LP ("AS 2018") and 236,128 shares held by Adams Street Venture/Growth VI LP ("ASVG VI"). F2: Adams Street Partners, LLC, as the managing member of the general partner of the general partner of each of AS 2011, AS 2012, AS 2013, AS 2014, AS 2015, AS 2016, AS 2017, AS 2018 and ASVG VI (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: Represents 694,854 shares held by Adams Street 2011 Direct Fund LP ("AS 2011"), 715,361 shares held by Adams Street 2012 Direct Fund LP ("AS 2012"), 541,133 shares held by Adams Street 2013 Direct Fund LP ("AS 2013"), 736,033 shares held by Adams Street 2014 Direct Fund LP ("AS 2014"), 69,864 shares held by Adams Street 2015 Direct Venture/Growth Fund LP ("AS 2015"), 67,769 shares held by Adams Street 2016 Direct Venture/Growth Fund LP ("AS 2016"), 87,668 shares held by Adams Street 2017 Direct Venture/Growth Fund LP ("AS 2017"), 126,806 shares held by Adams Street 2018 Direct Venture/Growth Fund LP ("AS 2018") and 236,128 shares held by Adams Street Venture/Growth VI LP ("ASVG VI").

F2: Adams Street Partners, LLC, as the managing member of the general partner of the general partner of each of AS 2011, AS 2012, AS 2013, AS 2014, AS 2015, AS 2016, AS 2017, AS 2018 and ASVG VI (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein.

F3: The underlying shares subject to the option vest and become exercisable as to one-twelfth (1/12th) of the shares subject to the option in successive, equal monthly installments measured from August 11, 2022, subject to Elisha P. Gould's continued service relationship with the Issuer on each such vesting date.

F4: This option was granted to Elisha P. Gould, a director of Corvus Pharmaceuticals, Inc., who is a partner of Adams Street Partners, LLC. Adams Street Partners, LLC is the managing member of the general partner of the general partner of each of the Funds. By agreement with the Funds, Mr. Gould is deemed to hold the option for the benefit of the Funds. The option may be deemed to be indirectly beneficially owned by Adams Street Partners, LLC. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), disclaim beneficial ownership of the option except to the extent of the pecuniary interest therein.

Q2 Holdings, Inc.

Report date May 24, 2017 · Filed May 26, 2017

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectSee footnote	3,443,275	Reported balance After 2017-05-24 transaction · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · 2017-05-24 · Other · Acquired 14,808 · Balance 3,443,275 F1: Represents 3,366 shares received by Adams Street Partnership Fund - 2007 U.S. Fund, L.P. (AS 2007 US), 4,317 shares received by Adams Street Partnership Fund - 2008 U.S. Fund, L.P. (AS 2008 US), 3,830 shares received by Adams Street Partnership Fund - 2009 U.S. Fund, L.P. (AS 2009 US), 2,695 shares received by Adams Street Partnership Fund - 2010 U.S. Fund, L.P. (AS 2010 US), and 600 shares received by Adams Street Partnership Fund - 2010 U.S. Fund - Series B, L.P. (AS 2010 US Series B), in each case, for no consideration as part of a pro-rata distribution of shares by a fund controlled by Battery Ventures. F2: Represents 1,068,616 shares held by Adams Street 2006 Direct Fund, L.P. (AS 2006), 1,206,764 shares held by Adams Street 2007 Direct Fund, L.P. (AS 2007), 404,299 shares held by Adams Street 2008 Direct Fund, L.P. (AS 2008), 349,690 shares held by Adams Street 2009 Direct Fund, L.P. (AS 2009), 198,644 shares held by Adams Street 2010 Direct Fund, L.P. (AS 2010), 159,589 shares held by Adams Street 2011 Direct Fund LP (AS 2011), 12,653 shares held by AS 2007 US, 16,230 shares held by AS 2008 US, 14,400 shares held by AS 2009 US, 10,132 shares held by AS 2010 US, and 2,258 shares held by AS 2010 US Series B. F3: The shares owned by each of AS 2006, AS 2007, AS 2008, AS 2009, AS 2010, AS 2011, AS 2007 US, AS 2008 US, AS 2009 US, AS 2010 US, and AS 2010 US Series B (the aforementioned funds, the "Funds") may be deemed to be beneficially owned by Adams Street Partners, LLC, the managing member of the general partner of each of AS 2006, AS 2007, AS 2008, AS 2009 and AS 2010, the managing member of the general partner of the general partner of AS 2011, and the general partner of AS 2007 US, AS 2008 US, AS 2009 US, AS 2010 US, and AS 2010 US Series B. F4: (Continued from Footnote 3) Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, Fred Wang and Michael R. Zappert, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to share voting and dispositive power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, Fred Wang and Michael R. Zappert disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectSee footnote	899	Reported balance Holding disclosure · report date 2017-05-24 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 899 F5: The shares are held by Jeffrey T. Diehl, who is a partner of Adams Street Partners, LLC ("ASP"). ASP is the managing member of the general partner of each of AS 2006, AS 2007, AS 2008, AS 2009, and AS 2010, the managing member of the general partner of the general partner of AS 2011 (the aforementioned direct funds, the "Direct Funds"), and the general partner of AS 2007 US, AS 2008 US, AS 2009 US, AS 2010 US, and AS 2010 US Series B. By agreement with the Direct Funds, Mr. Diehl is deemed to hold the shares for the benefit of the Direct Funds. F6: (Continued from Footnote 5) The shares may be deemed to be beneficially owned by ASP. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, Fred Wang and Michael R. Zappert, each of whom is a partner of ASP (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares. ASP and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, Fred Wang and Michael R. Zappert disclaim beneficial ownership of the shares except to the extent of their pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: Represents 3,366 shares received by Adams Street Partnership Fund - 2007 U.S. Fund, L.P. (AS 2007 US), 4,317 shares received by Adams Street Partnership Fund - 2008 U.S. Fund, L.P. (AS 2008 US), 3,830 shares received by Adams Street Partnership Fund - 2009 U.S. Fund, L.P. (AS 2009 US), 2,695 shares received by Adams Street Partnership Fund - 2010 U.S. Fund, L.P. (AS 2010 US), and 600 shares received by Adams Street Partnership Fund - 2010 U.S. Fund - Series B, L.P. (AS 2010 US Series B), in each case, for no consideration as part of a pro-rata distribution of shares by a fund controlled by Battery Ventures.

F2: Represents 1,068,616 shares held by Adams Street 2006 Direct Fund, L.P. (AS 2006), 1,206,764 shares held by Adams Street 2007 Direct Fund, L.P. (AS 2007), 404,299 shares held by Adams Street 2008 Direct Fund, L.P. (AS 2008), 349,690 shares held by Adams Street 2009 Direct Fund, L.P. (AS 2009), 198,644 shares held by Adams Street 2010 Direct Fund, L.P. (AS 2010), 159,589 shares held by Adams Street 2011 Direct Fund LP (AS 2011), 12,653 shares held by AS 2007 US, 16,230 shares held by AS 2008 US, 14,400 shares held by AS 2009 US, 10,132 shares held by AS 2010 US, and 2,258 shares held by AS 2010 US Series B.

F3: The shares owned by each of AS 2006, AS 2007, AS 2008, AS 2009, AS 2010, AS 2011, AS 2007 US, AS 2008 US, AS 2009 US, AS 2010 US, and AS 2010 US Series B (the aforementioned funds, the "Funds") may be deemed to be beneficially owned by Adams Street Partners, LLC, the managing member of the general partner of each of AS 2006, AS 2007, AS 2008, AS 2009 and AS 2010, the managing member of the general partner of the general partner of AS 2011, and the general partner of AS 2007 US, AS 2008 US, AS 2009 US, AS 2010 US, and AS 2010 US Series B.

F4: (Continued from Footnote 3) Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, Fred Wang and Michael R. Zappert, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to share voting and dispositive power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, Fred Wang and Michael R. Zappert disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein.

F5: The shares are held by Jeffrey T. Diehl, who is a partner of Adams Street Partners, LLC ("ASP"). ASP is the managing member of the general partner of each of AS 2006, AS 2007, AS 2008, AS 2009, and AS 2010, the managing member of the general partner of the general partner of AS 2011 (the aforementioned direct funds, the "Direct Funds"), and the general partner of AS 2007 US, AS 2008 US, AS 2009 US, AS 2010 US, and AS 2010 US Series B. By agreement with the Direct Funds, Mr. Diehl is deemed to hold the shares for the benefit of the Direct Funds.

F6: (Continued from Footnote 5) The shares may be deemed to be beneficially owned by ASP. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, Fred Wang and Michael R. Zappert, each of whom is a partner of ASP (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares. ASP and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, Fred Wang and Michael R. Zappert disclaim beneficial ownership of the shares except to the extent of their pecuniary interest therein.

Rimini Street, Inc.

Report date June 03, 2025 · Filed June 05, 2025

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectSee Footnote	272,994	Reported balance After 2025-06-03 transaction · row 10 Holding and transaction disclosures are not merged. 1 source row Row 10 · 2025-06-03 · Exercise / conversion · Acquired 65,335 · Balance 272,994 F10: On June 6, 2024, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 65,335 Restricted Stock Units which vested 100% on June 3, 2025 or the day before the date of the Issuer's 2025 Annual Meeting of Stockholders. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting. F11: The shares of common stock were issued to Robin Murray, a director of the Issuer, who is a partner of Adams Street Partners, LLC. Adams Street Partners, LLC is the managing member of the general partner of AS 2007, AS 2008 and AS 2009, is the managing member of the general partner of the general partner of AS 2013, AS 2014, AS 2015, AS 2016 and AS VGVI (collectively, the "Funds") and is the manager of ASRA. By agreement with the Funds, Mr. Murray is deemed to hold the common stock for the benefit of the Funds. F12: The common stock may be deemed to be indirectly beneficially owned by Adams Street Partners, LLC. Each of Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), disclaim beneficial ownership of the common stock except to the extent of their pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectSee Footnote	4,320,786	Reported balance Holding disclosure · report date 2025-06-03 · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · Balance 4,320,786 F1: Represents shares held directly by Adams Street 2007 Direct Fund, L.P. ("AS 2007"). Adams Street Partners, LLC, as the managing member of the general partner of AS 2007, may be deemed to beneficially own the shares held by AS 2007. Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Robin Murray, and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by AS 2007. Each of Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Robin Murray, and Fred Wang disclaim beneficial ownership of the shares held by AS 2007 except to the extent of their pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectSee Footnote	4,870,262	Reported balance Holding disclosure · report date 2025-06-03 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 4,870,262 F2: Represents shares held directly by Adams Street 2008 Direct Fund, L.P. ("AS 2008"). Adams Street Partners, LLC, as the managing member of the general partner of AS 2008, may be deemed to beneficially own the shares held by AS 2008. Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Robin Murray, and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by AS 2008. Each of Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Robin Murray, and Fred Wang disclaim beneficial ownership of the shares held by AS 2008 except to the extent of their pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectSee Footnote	4,267,067	Reported balance Holding disclosure · report date 2025-06-03 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 4,267,067 F3: Represents shares held directly by Adams Street 2009 Direct Fund, L.P. ("AS 2009"). Adams Street Partners, LLC, as the managing member of the general partner of AS 2009, may be deemed to beneficially own the shares held by AS 2009. Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Robin Murray, and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by AS 2009. Each of Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Robin Murray, and Fred Wang disclaim beneficial ownership of the shares held by AS 2009 except to the extent of their pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectSee Footnote	1,313,301	Reported balance Holding disclosure · report date 2025-06-03 · row 4 Holding and transaction disclosures are not merged. 1 source row Row 4 · Balance 1,313,301 F4: Represents shares held directly by Adams Street 2013 Direct Fund LP ("AS 2013"). Adams Street Partners, LLC, as the managing member of the general partner of the general partner of AS 2013, may be deemed to beneficially own the shares held by AS 2013. Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Robin Murray, and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by AS 2013. Each of Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Robin Murray, and Fred Wang disclaim beneficial ownership of the shares held by AS 2013 except to the extent of their pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectSee Footnote	1,786,318	Reported balance Holding disclosure · report date 2025-06-03 · row 5 Holding and transaction disclosures are not merged. 1 source row Row 5 · Balance 1,786,318 F5: Represents shares held directly by Adams Street 2014 Direct Fund LP ("AS 2014"). Adams Street Partners, LLC, as the managing member of the general partner of the general partner of AS 2014, may be deemed to beneficially own the shares held by AS 2014. Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Robin Murray, and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by AS 2014. Each of Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Robin Murray, and Fred Wang disclaim beneficial ownership of the shares held by AS 2014 except to the extent of their pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectSee Footnote	1,371,200	Reported balance Holding disclosure · report date 2025-06-03 · row 6 Holding and transaction disclosures are not merged. 1 source row Row 6 · Balance 1,371,200 F6: Represents shares held directly by Adams Street 2015 Direct Venture/Growth Fund LP ("AS 2015"). Adams Street Partners, LLC, as the managing member of the general partner of the general partner of AS 2015, may be deemed to beneficially own the shares held by AS 2015. Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Robin Murray, and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by AS 2015. Each of Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Robin Murray, and Fred Wang disclaim beneficial ownership of the shares held by AS 2015 except to the extent of their pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectSee Footnote	1,353,906	Reported balance Holding disclosure · report date 2025-06-03 · row 7 Holding and transaction disclosures are not merged. 1 source row Row 7 · Balance 1,353,906 F7: Represents shares held directly by Adams Street 2016 Direct Venture/Growth Fund LP ("AS 2016"). Adams Street Partners, LLC, as the managing member of the general partner of the general partner of AS 2016, may be deemed to beneficially own the shares held by AS 2016. Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Robin Murray, and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by AS 2016. Each of Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Robin Murray, and Fred Wang disclaim beneficial ownership of the shares held by AS 2016 except to the extent of their pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectSee Footnote	3,982,079	Reported balance Holding disclosure · report date 2025-06-03 · row 8 Holding and transaction disclosures are not merged. 1 source row Row 8 · Balance 3,982,079 F8: Represents shares held directly by Adams Street Venture/Growth Fund VI LP ("AS VGVI"). Adams Street Partners, LLC, as the managing member of the general partner of the general partner of AS VGVI, may be deemed to beneficially own the shares held by AS VGVI. Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Robin Murray, and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by AS VGVI. Each of Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Robin Murray, and Fred Wang disclaim beneficial ownership of the shares held by AS VGVI except to the extent of their pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectSee Footnote	300,514	Reported balance Holding disclosure · report date 2025-06-03 · row 9 Holding and transaction disclosures are not merged. 1 source row Row 9 · Balance 300,514 F9: Represents shares held directly by Adams Street Rimini Aggregator LLC ("ASRA"). Adams Street Partners, LLC, as the manager of ASRA, may be deemed to beneficially own the shares held by ASRA. David Brett, Alex Kessel, Michael Taylor, Benjamin Wallwork, Andy Wang and Craig D. Waslin, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by ASRA. Each of Adams Street Partners, LLC and David Brett, Alex Kessel, Michael Taylor, Benjamin Wallwork, Andy Wang and Craig D. Waslin disclaim beneficial ownership of the shares held by ASRA except to the extent of their pecuniary interest therein.
Restricted Stock UnitSEC Table II · derivative / convertible security	IndirectSee Footnote	0	Reported balance After 2025-06-03 transaction · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · 2025-06-03 · Exercise / conversion · Disposed 65,335 · Balance 0 F10: On June 6, 2024, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 65,335 Restricted Stock Units which vested 100% on June 3, 2025 or the day before the date of the Issuer's 2025 Annual Meeting of Stockholders. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting. F13: These Restricted Stock Units were granted to Robin Murray, a director of the Issuer, who is a partner of Adams Street Partners, LLC. Adams Street Partners, LLC is the managing member of the general partner of AS 2007, AS 2008 and AS 2009, the managing member of the general partner of the general partner of each of AS 2013, AS 2014, AS 2015, AS 2016 and AS VGVI, and the manager of ASRA. By agreement with the Funds, Mr. Murray is deemed to hold the Restricted Stock Units for the benefit of the Funds. F14: The Restricted Stock Units may be deemed to be indirectly beneficially owned by Adams Street Partners, LLC. Each of Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), disclaim beneficial ownership of the Restricted Stock Units except to the extent of their pecuniary interest therein.
Restricted Stock UnitSEC Table II · derivative / convertible security	IndirectSee Footnote	55,727	Reported balance After 2025-06-04 transaction · row 12 Instrument identity requires review; Table II rows are not merged. 1 source row Row 12 · 2025-06-04 · Grant · Acquired 55,727 · Balance 55,727 F15: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting. F16: 100% of the Restricted Stock Units awarded will vest on the earlier to occur of (i) June 4, 2026 or (ii) the day before the date of the Issuer's 2026 Annual Meeting of Stockholders, contingent upon Robin Murray's continued service as a member of the Issuer's Board of Directors through such date. F13: These Restricted Stock Units were granted to Robin Murray, a director of the Issuer, who is a partner of Adams Street Partners, LLC. Adams Street Partners, LLC is the managing member of the general partner of AS 2007, AS 2008 and AS 2009, the managing member of the general partner of the general partner of each of AS 2013, AS 2014, AS 2015, AS 2016 and AS VGVI, and the manager of ASRA. By agreement with the Funds, Mr. Murray is deemed to hold the Restricted Stock Units for the benefit of the Funds. F14: The Restricted Stock Units may be deemed to be indirectly beneficially owned by Adams Street Partners, LLC. Each of Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), disclaim beneficial ownership of the Restricted Stock Units except to the extent of their pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: Represents shares held directly by Adams Street 2007 Direct Fund, L.P. ("AS 2007"). Adams Street Partners, LLC, as the managing member of the general partner of AS 2007, may be deemed to beneficially own the shares held by AS 2007. Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Robin Murray, and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by AS 2007. Each of Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Robin Murray, and Fred Wang disclaim beneficial ownership of the shares held by AS 2007 except to the extent of their pecuniary interest therein.

F2: Represents shares held directly by Adams Street 2008 Direct Fund, L.P. ("AS 2008"). Adams Street Partners, LLC, as the managing member of the general partner of AS 2008, may be deemed to beneficially own the shares held by AS 2008. Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Robin Murray, and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by AS 2008. Each of Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Robin Murray, and Fred Wang disclaim beneficial ownership of the shares held by AS 2008 except to the extent of their pecuniary interest therein.

F3: Represents shares held directly by Adams Street 2009 Direct Fund, L.P. ("AS 2009"). Adams Street Partners, LLC, as the managing member of the general partner of AS 2009, may be deemed to beneficially own the shares held by AS 2009. Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Robin Murray, and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by AS 2009. Each of Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Robin Murray, and Fred Wang disclaim beneficial ownership of the shares held by AS 2009 except to the extent of their pecuniary interest therein.

F4: Represents shares held directly by Adams Street 2013 Direct Fund LP ("AS 2013"). Adams Street Partners, LLC, as the managing member of the general partner of the general partner of AS 2013, may be deemed to beneficially own the shares held by AS 2013. Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Robin Murray, and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by AS 2013. Each of Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Robin Murray, and Fred Wang disclaim beneficial ownership of the shares held by AS 2013 except to the extent of their pecuniary interest therein.

F5: Represents shares held directly by Adams Street 2014 Direct Fund LP ("AS 2014"). Adams Street Partners, LLC, as the managing member of the general partner of the general partner of AS 2014, may be deemed to beneficially own the shares held by AS 2014. Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Robin Murray, and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by AS 2014. Each of Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Robin Murray, and Fred Wang disclaim beneficial ownership of the shares held by AS 2014 except to the extent of their pecuniary interest therein.

F6: Represents shares held directly by Adams Street 2015 Direct Venture/Growth Fund LP ("AS 2015"). Adams Street Partners, LLC, as the managing member of the general partner of the general partner of AS 2015, may be deemed to beneficially own the shares held by AS 2015. Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Robin Murray, and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by AS 2015. Each of Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Robin Murray, and Fred Wang disclaim beneficial ownership of the shares held by AS 2015 except to the extent of their pecuniary interest therein.

F7: Represents shares held directly by Adams Street 2016 Direct Venture/Growth Fund LP ("AS 2016"). Adams Street Partners, LLC, as the managing member of the general partner of the general partner of AS 2016, may be deemed to beneficially own the shares held by AS 2016. Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Robin Murray, and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by AS 2016. Each of Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Robin Murray, and Fred Wang disclaim beneficial ownership of the shares held by AS 2016 except to the extent of their pecuniary interest therein.

F8: Represents shares held directly by Adams Street Venture/Growth Fund VI LP ("AS VGVI"). Adams Street Partners, LLC, as the managing member of the general partner of the general partner of AS VGVI, may be deemed to beneficially own the shares held by AS VGVI. Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Robin Murray, and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by AS VGVI. Each of Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Robin Murray, and Fred Wang disclaim beneficial ownership of the shares held by AS VGVI except to the extent of their pecuniary interest therein.

F9: Represents shares held directly by Adams Street Rimini Aggregator LLC ("ASRA"). Adams Street Partners, LLC, as the manager of ASRA, may be deemed to beneficially own the shares held by ASRA. David Brett, Alex Kessel, Michael Taylor, Benjamin Wallwork, Andy Wang and Craig D. Waslin, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by ASRA. Each of Adams Street Partners, LLC and David Brett, Alex Kessel, Michael Taylor, Benjamin Wallwork, Andy Wang and Craig D. Waslin disclaim beneficial ownership of the shares held by ASRA except to the extent of their pecuniary interest therein.

F10: On June 6, 2024, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 65,335 Restricted Stock Units which vested 100% on June 3, 2025 or the day before the date of the Issuer's 2025 Annual Meeting of Stockholders. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting.

F11: The shares of common stock were issued to Robin Murray, a director of the Issuer, who is a partner of Adams Street Partners, LLC. Adams Street Partners, LLC is the managing member of the general partner of AS 2007, AS 2008 and AS 2009, is the managing member of the general partner of the general partner of AS 2013, AS 2014, AS 2015, AS 2016 and AS VGVI (collectively, the "Funds") and is the manager of ASRA. By agreement with the Funds, Mr. Murray is deemed to hold the common stock for the benefit of the Funds.

F12: The common stock may be deemed to be indirectly beneficially owned by Adams Street Partners, LLC. Each of Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), disclaim beneficial ownership of the common stock except to the extent of their pecuniary interest therein.

F13: These Restricted Stock Units were granted to Robin Murray, a director of the Issuer, who is a partner of Adams Street Partners, LLC. Adams Street Partners, LLC is the managing member of the general partner of AS 2007, AS 2008 and AS 2009, the managing member of the general partner of the general partner of each of AS 2013, AS 2014, AS 2015, AS 2016 and AS VGVI, and the manager of ASRA. By agreement with the Funds, Mr. Murray is deemed to hold the Restricted Stock Units for the benefit of the Funds.

F14: The Restricted Stock Units may be deemed to be indirectly beneficially owned by Adams Street Partners, LLC. Each of Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), disclaim beneficial ownership of the Restricted Stock Units except to the extent of their pecuniary interest therein.

F15: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting.

F16: 100% of the Restricted Stock Units awarded will vest on the earlier to occur of (i) June 4, 2026 or (ii) the day before the date of the Issuer's 2026 Annual Meeting of Stockholders, contingent upon Robin Murray's continued service as a member of the Issuer's Board of Directors through such date.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Fusion Pharmaceuticals Inc.

Report date December 24, 2020 · Filed December 29, 2020

Section 16 reporting ended · disclosed 2020-12-29. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectSee footnotes	561,634	Reported balance After 2020-12-24 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2020-12-24 · Sale · Disposed 611 · Balance 561,634 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.81 to $12.00. F2: The shares are held directly by Adams Street 2014 Direct Fund LP ("AS 2014"). F7: Adams Street Partners, LLC as the managing member of the general partner of the general partner of each of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectSee footnotes	431,117	Reported balance After 2020-12-24 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 2 · 2020-12-24 · Sale · Disposed 469 · Balance 431,117 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.81 to $12.00. F3: The shares are held directly by Adams Street 2015 Direct Venture/Growth Fund LP ("AS 2015"). F7: Adams Street Partners, LLC as the managing member of the general partner of the general partner of each of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectSee footnotes	418,190	Reported balance After 2020-12-24 transaction · row 3 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 3 · 2020-12-24 · Sale · Disposed 455 · Balance 418,190 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.81 to $12.00. F4: The shares are held directly by Adams Street 2016 Direct Venture/Growth Fund LP ("AS 2016"). F7: Adams Street Partners, LLC as the managing member of the general partner of the general partner of each of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectSee footnotes	626,000	Reported balance After 2020-12-24 transaction · row 4 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 4 · 2020-12-24 · Sale · Disposed 681 · Balance 626,000 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.81 to $12.00. F5: The shares are held directly by Adams Street 2017 Direct Venture/Growth Fund LP ("AS 2017"). F7: Adams Street Partners, LLC as the managing member of the general partner of the general partner of each of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectSee footnotes	1,457,115	Reported balance After 2020-12-24 transaction · row 5 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 5 · 2020-12-24 · Sale · Disposed 1,584 · Balance 1,457,115 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.81 to $12.00. F6: The shares are held directly by Adams Street Venture/Growth Fund VI LP ("ASVG VI"). F7: Adams Street Partners, LLC as the managing member of the general partner of the general partner of each of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.81 to $12.00.

F2: The shares are held directly by Adams Street 2014 Direct Fund LP ("AS 2014").

F3: The shares are held directly by Adams Street 2015 Direct Venture/Growth Fund LP ("AS 2015").

F4: The shares are held directly by Adams Street 2016 Direct Venture/Growth Fund LP ("AS 2016").

F5: The shares are held directly by Adams Street 2017 Direct Venture/Growth Fund LP ("AS 2017").

F6: The shares are held directly by Adams Street Venture/Growth Fund VI LP ("ASVG VI").

F7: Adams Street Partners, LLC as the managing member of the general partner of the general partner of each of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein.

Icosavax, Inc.

Report date August 02, 2021 · Filed August 03, 2021

Section 16 reporting ended · disclosed 2021-08-03. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectSee footnotes	948,188	Reported balance After 2021-08-02 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2021-08-02 · Conversion · Acquired 948,188 · Balance 948,188 F9: Includes additional shares of Common Stock as a result of the conversion of Preferred Stock calculated on an aggregate basis of all shares of Preferred Stock held by the holder. F1: On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer. F2: The shares are held directly by Adams Street Venture/Growth Fund VI LP ("ASVG VI"). F8: Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectSee footnotes	996,169	Reported balance After 2021-08-02 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 2 · 2021-08-02 · Purchase · Acquired 47,981 · Balance 996,169 F10: ASVG VI acquired additional shares in the Issuer's initial public offering. F2: The shares are held directly by Adams Street Venture/Growth Fund VI LP ("ASVG VI"). F8: Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectSee footnotes	916,558	Reported balance After 2021-08-02 transaction · row 3 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 3 · 2021-08-02 · Conversion · Acquired 916,558 · Balance 916,558 F1: On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer. F3: The shares are held directly by Adams Street Growth Equity Fund VII LP ("AS GE VII"). F8: Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectSee footnotes	962,939	Reported balance After 2021-08-02 transaction · row 4 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 4 · 2021-08-02 · Purchase · Acquired 46,381 · Balance 962,939 F11: AS GE VII acquired additional shares in the Issuer's initial public offering. F3: The shares are held directly by Adams Street Growth Equity Fund VII LP ("AS GE VII"). F8: Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectSee footnotes	272,131	Reported balance After 2021-08-02 transaction · row 5 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 5 · 2021-08-02 · Conversion · Acquired 272,131 · Balance 272,131 F9: Includes additional shares of Common Stock as a result of the conversion of Preferred Stock calculated on an aggregate basis of all shares of Preferred Stock held by the holder. F1: On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer. F4: The shares are held directly by Adams Street 2016 Direct Venture/Growth Fund LP ("AS 2016"). F8: Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectSee footnotes	352,037	Reported balance After 2021-08-02 transaction · row 6 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 6 · 2021-08-02 · Conversion · Acquired 352,037 · Balance 352,037 F1: On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer. F5: The shares are held directly by Adams Street 2017 Direct Venture/Growth Fund LP ("AS 2017"). F8: Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectSee footnotes	525,729	Reported balance After 2021-08-02 transaction · row 7 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 7 · 2021-08-02 · Conversion · Acquired 525,729 · Balance 525,729 F9: Includes additional shares of Common Stock as a result of the conversion of Preferred Stock calculated on an aggregate basis of all shares of Preferred Stock held by the holder. F1: On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer. F6: The shares are held directly by Adams Street 2018 Direct Venture/Growth Fund LP ("AS 2018"). F8: Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectSee footnotes	552,333	Reported balance After 2021-08-02 transaction · row 8 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 8 · 2021-08-02 · Purchase · Acquired 26,604 · Balance 552,333 F12: AS 2018 acquired additional shares in the Issuer's initial public offering. F6: The shares are held directly by Adams Street 2018 Direct Venture/Growth Fund LP ("AS 2018"). F8: Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectSee footnotes	244,415	Reported balance After 2021-08-02 transaction · row 9 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 9 · 2021-08-02 · Conversion · Acquired 244,415 · Balance 244,415 F1: On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer. F7: The shares are held directly by Adams Street 2019 Direct Growth Equity Fund LP ("AS 2019"). F8: Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectSee footnotes	256,783	Reported balance After 2021-08-02 transaction · row 10 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 10 · 2021-08-02 · Purchase · Acquired 12,368 · Balance 256,783 F13: AS 2019 acquired additional shares in the Issuer's initial public offering. F7: The shares are held directly by Adams Street 2019 Direct Growth Equity Fund LP ("AS 2019"). F8: Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein.
Series A-1 Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	IndirectSee footnotes	0	Reported balance After 2021-08-02 transaction · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · 2021-08-02 · Conversion · Disposed 3,631,066 · Balance 0 F1: On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer. F2: The shares are held directly by Adams Street Venture/Growth Fund VI LP ("ASVG VI"). F8: Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein.
Series A-1 Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	IndirectSee footnotes	0	Reported balance After 2021-08-02 transaction · row 12 Instrument identity requires review; Table II rows are not merged. 1 source row Row 12 · 2021-08-02 · Conversion · Disposed 3,509,939 · Balance 0 F1: On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer. F3: The shares are held directly by Adams Street Growth Equity Fund VII LP ("AS GE VII"). F8: Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein.
Series A-1 Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	IndirectSee footnotes	0	Reported balance After 2021-08-02 transaction · row 13 Instrument identity requires review; Table II rows are not merged. 1 source row Row 13 · 2021-08-02 · Conversion · Disposed 1,042,120 · Balance 0 F1: On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer. F4: The shares are held directly by Adams Street 2016 Direct Venture/Growth Fund LP ("AS 2016"). F8: Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein.
Series A-1 Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	IndirectSee footnotes	0	Reported balance After 2021-08-02 transaction · row 14 Instrument identity requires review; Table II rows are not merged. 1 source row Row 14 · 2021-08-02 · Conversion · Disposed 1,348,119 · Balance 0 F1: On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer. F5: The shares are held directly by Adams Street 2017 Direct Venture/Growth Fund LP ("AS 2017"). F8: Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein.
Series A-1 Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	IndirectSee footnotes	0	Reported balance After 2021-08-02 transaction · row 15 Instrument identity requires review; Table II rows are not merged. 1 source row Row 15 · 2021-08-02 · Conversion · Disposed 2,013,269 · Balance 0 F1: On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer. F6: The shares are held directly by Adams Street 2018 Direct Venture/Growth Fund LP ("AS 2018"). F8: Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein.
Series A-1 Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	IndirectSee footnotes	0	Reported balance After 2021-08-02 transaction · row 16 Instrument identity requires review; Table II rows are not merged. 1 source row Row 16 · 2021-08-02 · Conversion · Disposed 935,985 · Balance 0 F1: On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer. F7: The shares are held directly by Adams Street 2019 Direct Growth Equity Fund LP ("AS 2019"). F8: Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein.
Series B-1 Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	IndirectSee footnotes	0	Reported balance After 2021-08-02 transaction · row 17 Instrument identity requires review; Table II rows are not merged. 1 source row Row 17 · 2021-08-02 · Conversion · Disposed 309,321 · Balance 0 F1: On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer. F2: The shares are held directly by Adams Street Venture/Growth Fund VI LP ("ASVG VI"). F8: Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein.
Series B-1 Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	IndirectSee footnotes	0	Reported balance After 2021-08-02 transaction · row 18 Instrument identity requires review; Table II rows are not merged. 1 source row Row 18 · 2021-08-02 · Conversion · Disposed 299,003 · Balance 0 F1: On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer. F3: The shares are held directly by Adams Street Growth Equity Fund VII LP ("AS GE VII"). F8: Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein.
Series B-1 Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	IndirectSee footnotes	0	Reported balance After 2021-08-02 transaction · row 19 Instrument identity requires review; Table II rows are not merged. 1 source row Row 19 · 2021-08-02 · Conversion · Disposed 88,775 · Balance 0 F1: On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer. F4: The shares are held directly by Adams Street 2016 Direct Venture/Growth Fund LP ("AS 2016"). F8: Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein.
Series B-1 Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	IndirectSee footnotes	0	Reported balance After 2021-08-02 transaction · row 20 Instrument identity requires review; Table II rows are not merged. 1 source row Row 20 · 2021-08-02 · Conversion · Disposed 114,843 · Balance 0 F1: On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer. F5: The shares are held directly by Adams Street 2017 Direct Venture/Growth Fund LP ("AS 2017"). F8: Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein.
Series B-1 Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	IndirectSee footnotes	0	Reported balance After 2021-08-02 transaction · row 21 Instrument identity requires review; Table II rows are not merged. 1 source row Row 21 · 2021-08-02 · Conversion · Disposed 171,505 · Balance 0 F1: On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer. F6: The shares are held directly by Adams Street 2018 Direct Venture/Growth Fund LP ("AS 2018"). F8: Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein.
Series B-1 Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	IndirectSee footnotes	0	Reported balance After 2021-08-02 transaction · row 22 Instrument identity requires review; Table II rows are not merged. 1 source row Row 22 · 2021-08-02 · Conversion · Disposed 79,734 · Balance 0 F1: On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer. F7: The shares are held directly by Adams Street 2019 Direct Growth Equity Fund LP ("AS 2019"). F8: Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer.

F2: The shares are held directly by Adams Street Venture/Growth Fund VI LP ("ASVG VI").

F3: The shares are held directly by Adams Street Growth Equity Fund VII LP ("AS GE VII").

F4: The shares are held directly by Adams Street 2016 Direct Venture/Growth Fund LP ("AS 2016").

F5: The shares are held directly by Adams Street 2017 Direct Venture/Growth Fund LP ("AS 2017").

F6: The shares are held directly by Adams Street 2018 Direct Venture/Growth Fund LP ("AS 2018").

F7: The shares are held directly by Adams Street 2019 Direct Growth Equity Fund LP ("AS 2019").

F8: Adams Street Partners, LLC as the managing member of the general partner of the general partner of ASVG VI, AS GE VII, AS 2016, AS 2017, AS 2018 and AS 2019 (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein.

F9: Includes additional shares of Common Stock as a result of the conversion of Preferred Stock calculated on an aggregate basis of all shares of Preferred Stock held by the holder.

F10: ASVG VI acquired additional shares in the Issuer's initial public offering.

F11: AS GE VII acquired additional shares in the Issuer's initial public offering.

F12: AS 2018 acquired additional shares in the Issuer's initial public offering.

F13: AS 2019 acquired additional shares in the Issuer's initial public offering.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
December 24, 2020 Filed Dec 29, 2020 16:01 UTC	Fusion Pharmaceuticals Inc. FUSN · Entity 11851	SaleCommon Stock	469	$12.32	$5,778.08	Disclosure SEC source: 0001104659-20-140145 · tm2039509d1_4.xml · nonDerivative · entry 2 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 431,117 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.81 to $12.00. F3 · ownership.nature: The shares are held directly by Adams Street 2015 Direct Venture/Growth Fund LP ("AS 2015"). F7 · ownership.nature: Adams Street Partners, LLC as the managing member of the general partner of the general partner of each of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein. Read SEC document
December 24, 2020 Filed Dec 29, 2020 16:01 UTC	Fusion Pharmaceuticals Inc. FUSN · Entity 11851	SaleCommon Stock	611	$12.32	$7,527.52	Disclosure SEC source: 0001104659-20-140145 · tm2039509d1_4.xml · nonDerivative · entry 1 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 561,634 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.81 to $12.00. F2 · ownership.nature: The shares are held directly by Adams Street 2014 Direct Fund LP ("AS 2014"). F7 · ownership.nature: Adams Street Partners, LLC as the managing member of the general partner of the general partner of each of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein. Read SEC document
December 23, 2020 Filed Dec 28, 2020 16:02 UTC	Fusion Pharmaceuticals Inc. FUSN · Entity 11851	SaleCommon Stock	1,905	$12.39	$23,602.95	Disclosure SEC source: 0001104659-20-139741 · tm2039377d1_4.xml · nonDerivative · entry 5 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,458,699 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.705 to $12.00. F6 · ownership.nature: The shares are held directly by Adams Street Venture/Growth Fund VI LP ("ASVG VI"). F7 · ownership.nature: Adams Street Partners, LLC as the managing member of the general partner of the general partner of each of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein. Read SEC document
December 23, 2020 Filed Dec 28, 2020 16:02 UTC	Fusion Pharmaceuticals Inc. FUSN · Entity 11851	SaleCommon Stock	819	$12.39	$10,147.41	Disclosure SEC source: 0001104659-20-139741 · tm2039377d1_4.xml · nonDerivative · entry 4 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 626,681 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.705 to $12.00. F5 · ownership.nature: The shares are held directly by Adams Street 2017 Direct Venture/Growth Fund LP ("AS 2017"). F7 · ownership.nature: Adams Street Partners, LLC as the managing member of the general partner of the general partner of each of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein. Read SEC document
December 23, 2020 Filed Dec 28, 2020 16:02 UTC	Fusion Pharmaceuticals Inc. FUSN · Entity 11851	SaleCommon Stock	547	$12.39	$6,777.33	Disclosure SEC source: 0001104659-20-139741 · tm2039377d1_4.xml · nonDerivative · entry 3 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 418,645 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.705 to $12.00. F4 · ownership.nature: The shares are held directly by Adams Street 2016 Direct Venture/Growth Fund LP ("AS 2016"). F7 · ownership.nature: Adams Street Partners, LLC as the managing member of the general partner of the general partner of each of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein. Read SEC document
December 23, 2020 Filed Dec 28, 2020 16:02 UTC	Fusion Pharmaceuticals Inc. FUSN · Entity 11851	SaleCommon Stock	564	$12.39	$6,987.96	Disclosure SEC source: 0001104659-20-139741 · tm2039377d1_4.xml · nonDerivative · entry 2 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 431,586 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.705 to $12.00. F3 · ownership.nature: The shares are held directly by Adams Street 2015 Direct Venture/Growth Fund LP ("AS 2015"). F7 · ownership.nature: Adams Street Partners, LLC as the managing member of the general partner of the general partner of each of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein. Read SEC document
December 23, 2020 Filed Dec 28, 2020 16:02 UTC	Fusion Pharmaceuticals Inc. FUSN · Entity 11851	SaleCommon Stock	734	$12.39	$9,094.26	Disclosure SEC source: 0001104659-20-139741 · tm2039377d1_4.xml · nonDerivative · entry 1 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 562,245 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.705 to $12.00. F2 · ownership.nature: The shares are held directly by Adams Street 2014 Direct Fund LP ("AS 2014"). F7 · ownership.nature: Adams Street Partners, LLC as the managing member of the general partner of the general partner of each of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein. Read SEC document
September 30, 2020 Filed Oct 2, 2020 16:01 UTC	Aptinyx Inc. APTX · Entity 120922	GrantStock Option (Right to Buy) · Derivative	4,623	$2.16 Strike: $3.38	$9,999.55	Disclosure SEC source: 0001104659-20-111684 · tm2032270d1_4.xml · derivative · entry 1 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 4,623 Underlying: Common Stock · 4,623 shares Expires 2030-09-29 F1 · shares: The option award was issued to Elisha P. ("Terry") Gould III, who elected to take equity awards in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant. F2 · derivative.exercise_date: This option is fully vested at time of grant. F3 · ownership.nature: Elisha P. Gould III is a partner of Adams Street Partners, LLC ("Adams Street"). Adams Street is the direct or indirect general partner/investment adviser of managed entities that own common stock of the Issuer. By agreement with certain of such Adams Street funds, Mr. Gould is deemed to hold the stock options for the benefit of those funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin Murray and Fred Wang, each of whom is a partner of Adams Street (or a subsidiary thereof) may be deemed to have shared voting and investment power over the options. Adams Street and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin Murray and Fred Wang disclaim beneficial ownership of the options except to the extent of their pecuniary interest therein. Read SEC document
July 09, 2020 Filed Jul 13, 2020 16:05 UTC	Aptinyx Inc. APTX · Entity 120922	OtherCommon Stock	90,124	$0.00	$0.00	Disclosure SEC source: 0001104659-20-083085 · tm2024585d1_4.xml · nonDerivative · entry 1 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 275,244 F1 · shares: Represents 20,246 shares received by Adams Street Partnership Fund - 2002 U.S. Fund, L.P. (AS 2002 US), 18,583 shares received by Adams Street Partnership Fund - 2003 U.S. Fund, L.P. (AS 2003 US), 14,354 shares received by Adams Street Partnership Fund - 2004 U.S. Fund, L.P. (AS 2004 US), 19,995 shares received by Adams Street Partnership Fund - 2005 U.S. Fund, L.P. (AS 2005 US), 1,186 shares received by Brinson Partnership Fund - 2004 Primary Fund, L.P. (BPF 2004 Primary), 796 shares received by The 2004 Primary Brinson Partnership Fund Offshore Series Company Ltd. (BPF 2004 Offshore), 2,472 shares received by Brinson Partnership Fund Trust - 2004 Primary Fund (BPF 2004 Trust) and 12,492 shares received by The Bank of New York Mellon as Trustee for the HP Inc. Master Trust (HP Trust), in each case, for no consideration as part of an exempt pro-rata distribution of shares on July 9, 2020 by a fund controlled by a third-party manager. F2 · balance_after: Represents 61,833 shares held by AS 2002 US, 56,753 shares held by AS 2003 US, 43,838 shares held by AS 2004 US, 61,066 shares held by AS 2005 US, 3,622 shares held by BPF 2004 Primary, 2,431 shares held by BPF 2004 Offshore, 7,550 shares held by BPF 2004 Trust and 38,151 shares held by HP Trust. All such shares were received for no consideration as part of exempt pro-rata distributions of shares by a fund controlled by a third-party manager. F3 · ownership.nature: The shares owned by each of AS 2002 US, AS 2003 US, AS 2004 US, AS 2005 US, BPF 2004 Primary, BPF 2004 Offshore, BPF 2004 Trust and HP Trust (the aforementioned funds, the "Funds") may be deemed to be beneficially owned by Adams Street Partners, LLC, the general partner of AS 2002 US, AS 2003 US, AS 2004 US and AS 2005 US; which is the sub-advisor and acts under power of attorney with respect to BPF 2004 Primary, BPF 2004 Offshore and BPF 2004 Trust; and which is the advisor and acts under power of attorney with respect to HP Trust. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to share voting and dispositive power over the shares held by the Funds. F4 · ownership.nature: Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein. Read SEC document
June 30, 2020 Filed Jul 2, 2020 16:01 UTC	Fusion Pharmaceuticals Inc. FUSN · Entity 11851	ConversionClass B Preferred Shares · Derivative	2,237,832	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-20-018254 · doc4.xml · derivative · entry 20 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Common Shares · 419,148 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares. F7 · price: The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares. F7 · derivative.exercise_date: The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares. F7 · derivative.expiration_date: The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares. F6 · ownership.nature: The shares are held directly by Adams Street Venture/Growth Fund VI LP ("ASVG VI"). F8 · ownership.nature: Adams Street Partners, LLC as the managing member of the general partner of the general partner of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein. Read SEC document
June 30, 2020 Filed Jul 2, 2020 16:01 UTC	Fusion Pharmaceuticals Inc. FUSN · Entity 11851	ConversionClass B Preferred Shares · Derivative	961,412	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-20-018254 · doc4.xml · derivative · entry 19 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Common Shares · 180,072 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares. F7 · price: The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares. F7 · derivative.exercise_date: The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares. F7 · derivative.expiration_date: The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares. F5 · ownership.nature: The shares are held directly by Adams Street 2017 Direct Venture/Growth Fund LP ("AS 2017"). F8 · ownership.nature: Adams Street Partners, LLC as the managing member of the general partner of the general partner of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein. Read SEC document
June 30, 2020 Filed Jul 2, 2020 16:01 UTC	Fusion Pharmaceuticals Inc. FUSN · Entity 11851	ConversionClass B Preferred Shares · Derivative	642,260	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-20-018254 · doc4.xml · derivative · entry 18 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Common Shares · 120,294 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares. F7 · price: The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares. F7 · derivative.exercise_date: The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares. F7 · derivative.expiration_date: The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares. F4 · ownership.nature: The shares are held directly by Adams Street 2016 Direct Venture/Growth Fund LP ("AS 2016"). F8 · ownership.nature: Adams Street Partners, LLC as the managing member of the general partner of the general partner of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein. Read SEC document
June 30, 2020 Filed Jul 2, 2020 16:01 UTC	Fusion Pharmaceuticals Inc. FUSN · Entity 11851	ConversionClass B Preferred Shares · Derivative	662,111	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-20-018254 · doc4.xml · derivative · entry 17 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Common Shares · 124,013 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares. F7 · price: The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares. F7 · derivative.exercise_date: The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares. F7 · derivative.expiration_date: The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares. F3 · ownership.nature: The shares are held directly by Adams Street 2015 Direct Venture/Growth Fund LP ("AS 2015"). F8 · ownership.nature: Adams Street Partners, LLC as the managing member of the general partner of the general partner of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein. Read SEC document
June 30, 2020 Filed Jul 2, 2020 16:01 UTC	Fusion Pharmaceuticals Inc. FUSN · Entity 11851	ConversionClass B Preferred Shares · Derivative	862,558	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-20-018254 · doc4.xml · derivative · entry 16 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Common Shares · 161,556 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares. F7 · price: The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares. F7 · derivative.exercise_date: The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares. F7 · derivative.expiration_date: The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares. F2 · ownership.nature: The shares are held directly by Adams Street 2014 Direct Fund LP ("AS 2014"). F8 · ownership.nature: Adams Street Partners, LLC as the managing member of the general partner of the general partner of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein. Read SEC document
June 30, 2020 Filed Jul 2, 2020 16:01 UTC	Fusion Pharmaceuticals Inc. FUSN · Entity 11851	ConversionClass A Preferred Shares · Derivative	5,560,341	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-20-018254 · doc4.xml · derivative · entry 15 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Common Shares · 1,041,456 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares. F1 · price: The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares. F1 · derivative.exercise_date: The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares. F1 · derivative.expiration_date: The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares. F6 · ownership.nature: The shares are held directly by Adams Street Venture/Growth Fund VI LP ("ASVG VI"). F8 · ownership.nature: Adams Street Partners, LLC as the managing member of the general partner of the general partner of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein. Read SEC document
June 30, 2020 Filed Jul 2, 2020 16:01 UTC	Fusion Pharmaceuticals Inc. FUSN · Entity 11851	ConversionClass A Preferred Shares · Derivative	2,388,822	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-20-018254 · doc4.xml · derivative · entry 14 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Common Shares · 447,428 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares. F1 · price: The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares. F1 · derivative.exercise_date: The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares. F1 · derivative.expiration_date: The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares. F5 · ownership.nature: The shares are held directly by Adams Street 2017 Direct Venture/Growth Fund LP ("AS 2017"). F8 · ownership.nature: Adams Street Partners, LLC as the managing member of the general partner of the general partner of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein. Read SEC document
June 30, 2020 Filed Jul 2, 2020 16:01 UTC	Fusion Pharmaceuticals Inc. FUSN · Entity 11851	ConversionClass A Preferred Shares · Derivative	1,595,823	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-20-018254 · doc4.xml · derivative · entry 13 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Common Shares · 298,898 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares. F1 · price: The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares. F1 · derivative.exercise_date: The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares. F1 · derivative.expiration_date: The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares. F4 · ownership.nature: The shares are held directly by Adams Street 2016 Direct Venture/Growth Fund LP ("AS 2016"). F8 · ownership.nature: Adams Street Partners, LLC as the managing member of the general partner of the general partner of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein. Read SEC document
June 30, 2020 Filed Jul 2, 2020 16:01 UTC	Fusion Pharmaceuticals Inc. FUSN · Entity 11851	ConversionClass A Preferred Shares · Derivative	1,645,147	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-20-018254 · doc4.xml · derivative · entry 12 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Common Shares · 308,137 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares. F1 · price: The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares. F1 · derivative.exercise_date: The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares. F1 · derivative.expiration_date: The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares. F3 · ownership.nature: The shares are held directly by Adams Street 2015 Direct Venture/Growth Fund LP ("AS 2015"). F8 · ownership.nature: Adams Street Partners, LLC as the managing member of the general partner of the general partner of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein. Read SEC document
June 30, 2020 Filed Jul 2, 2020 16:01 UTC	Fusion Pharmaceuticals Inc. FUSN · Entity 11851	ConversionClass A Preferred Shares · Derivative	2,143,200	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-20-018254 · doc4.xml · derivative · entry 11 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Common Shares · 401,423 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares. F1 · price: The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares. F1 · derivative.exercise_date: The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares. F1 · derivative.expiration_date: The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares. F2 · ownership.nature: The shares are held directly by Adams Street 2014 Direct Fund LP ("AS 2014"). F8 · ownership.nature: Adams Street Partners, LLC as the managing member of the general partner of the general partner of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein. Read SEC document
June 30, 2020 Filed Jul 2, 2020 16:01 UTC	Fusion Pharmaceuticals Inc. FUSN · Entity 11851	ConversionCommon Shares	419,148	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-20-018254 · doc4.xml · nonDerivative · entry 10 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,460,604 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · price: The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares. F6 · ownership.nature: The shares are held directly by Adams Street Venture/Growth Fund VI LP ("ASVG VI"). F8 · ownership.nature: Adams Street Partners, LLC as the managing member of the general partner of the general partner of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein. Read SEC document
June 30, 2020 Filed Jul 2, 2020 16:01 UTC	Fusion Pharmaceuticals Inc. FUSN · Entity 11851	ConversionCommon Shares	180,072	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-20-018254 · doc4.xml · nonDerivative · entry 9 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 627,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · price: The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares. F5 · ownership.nature: The shares are held directly by Adams Street 2017 Direct Venture/Growth Fund LP ("AS 2017"). F8 · ownership.nature: Adams Street Partners, LLC as the managing member of the general partner of the general partner of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein. Read SEC document
June 30, 2020 Filed Jul 2, 2020 16:01 UTC	Fusion Pharmaceuticals Inc. FUSN · Entity 11851	ConversionCommon Shares	120,294	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-20-018254 · doc4.xml · nonDerivative · entry 8 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 419,192 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · price: The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares. F4 · ownership.nature: The shares are held directly by Adams Street 2016 Direct Venture/Growth Fund LP ("AS 2016"). F8 · ownership.nature: Adams Street Partners, LLC as the managing member of the general partner of the general partner of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein. Read SEC document
June 30, 2020 Filed Jul 2, 2020 16:01 UTC	Fusion Pharmaceuticals Inc. FUSN · Entity 11851	ConversionCommon Shares	124,013	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-20-018254 · doc4.xml · nonDerivative · entry 7 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 432,150 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · price: The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares. F3 · ownership.nature: The shares are held directly by Adams Street 2015 Direct Venture/Growth Fund LP ("AS 2015"). F8 · ownership.nature: Adams Street Partners, LLC as the managing member of the general partner of the general partner of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein. Read SEC document
June 30, 2020 Filed Jul 2, 2020 16:01 UTC	Fusion Pharmaceuticals Inc. FUSN · Entity 11851	ConversionCommon Shares	161,556	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-20-018254 · doc4.xml · nonDerivative · entry 6 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 562,979 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · price: The Class B Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class B Preferred Shares converted into Common Shares. F2 · ownership.nature: The shares are held directly by Adams Street 2014 Direct Fund LP ("AS 2014"). F8 · ownership.nature: Adams Street Partners, LLC as the managing member of the general partner of the general partner of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein. Read SEC document
June 30, 2020 Filed Jul 2, 2020 16:01 UTC	Fusion Pharmaceuticals Inc. FUSN · Entity 11851	ConversionCommon Shares	1,041,456	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-20-018254 · doc4.xml · nonDerivative · entry 5 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,041,456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares. F6 · ownership.nature: The shares are held directly by Adams Street Venture/Growth Fund VI LP ("ASVG VI"). F8 · ownership.nature: Adams Street Partners, LLC as the managing member of the general partner of the general partner of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein. Read SEC document
June 30, 2020 Filed Jul 2, 2020 16:01 UTC	Fusion Pharmaceuticals Inc. FUSN · Entity 11851	ConversionCommon Shares	447,428	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-20-018254 · doc4.xml · nonDerivative · entry 4 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 447,428 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares. F5 · ownership.nature: The shares are held directly by Adams Street 2017 Direct Venture/Growth Fund LP ("AS 2017"). F8 · ownership.nature: Adams Street Partners, LLC as the managing member of the general partner of the general partner of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein. Read SEC document
June 30, 2020 Filed Jul 2, 2020 16:01 UTC	Fusion Pharmaceuticals Inc. FUSN · Entity 11851	ConversionCommon Shares	298,898	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-20-018254 · doc4.xml · nonDerivative · entry 3 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 298,898 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares. F4 · ownership.nature: The shares are held directly by Adams Street 2016 Direct Venture/Growth Fund LP ("AS 2016"). F8 · ownership.nature: Adams Street Partners, LLC as the managing member of the general partner of the general partner of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein. Read SEC document
June 30, 2020 Filed Jul 2, 2020 16:01 UTC	Fusion Pharmaceuticals Inc. FUSN · Entity 11851	ConversionCommon Shares	308,137	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-20-018254 · doc4.xml · nonDerivative · entry 2 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 308,137 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares. F3 · ownership.nature: The shares are held directly by Adams Street 2015 Direct Venture/Growth Fund LP ("AS 2015"). F8 · ownership.nature: Adams Street Partners, LLC as the managing member of the general partner of the general partner of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein. Read SEC document
June 30, 2020 Filed Jul 2, 2020 16:01 UTC	Fusion Pharmaceuticals Inc. FUSN · Entity 11851	ConversionCommon Shares	401,423	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-20-018254 · doc4.xml · nonDerivative · entry 1 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 401,423 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Class A Preferred Shares were convertible into Common Shares on a one-for-5.339 basis. Upon the closing of the Issuer's initial public offering, all Class A Preferred Shares converted into Common Shares. F2 · ownership.nature: The shares are held directly by Adams Street 2014 Direct Fund LP ("AS 2014"). F8 · ownership.nature: Adams Street Partners, LLC as the managing member of the general partner of the general partner of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein. Read SEC document
June 30, 2020 Filed Jul 2, 2020 16:02 UTC	Aptinyx Inc. APTX · Entity 120922	GrantStock Option (Right to Buy) · Derivative	3,735	$2.68 Strike: $4.17	$9,998.60	Disclosure SEC source: 0001104659-20-080528 · tm2024050d1_4.xml · derivative · entry 1 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,735 Underlying: Common Stock · 3,735 shares Expires 2030-06-29 F1 · shares: The option award was issued to Elisha P. ("Terry") Gould III, who elected to take equity awards in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant. F2 · derivative.exercise_date: This option is fully vested at time of grant. F3 · ownership.nature: Elisha P. Gould III is a partner of Adams Street Partners, LLC ("Adams Street"). Adams Street is the direct or indirect general partner/investment adviser of managed entities that own common stock of the Issuer. By agreement with certain of such Adams Street funds, Mr. Gould is deemed to hold the stock options for the benefit of those funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin Murray and Fred Wang, each of whom is a partner of Adams Street (or a subsidiary thereof) may be deemed to have shared voting and investment power over the options. Adams Street and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin Murray and Fred Wang disclaim beneficial ownership of the options except to the extent of their pecuniary interest therein. Read SEC document
June 09, 2020 Filed Jun 15, 2020 21:28 UTC	Corvus Pharmaceuticals, Inc. CRVS · Entity 4839	GrantStock Option (Right to Buy) · Derivative	15,000	$0.00 Strike: $3.27	$0.00	Disclosure SEC source: 0001104659-20-073458 · tm2022676d1_4.xml · derivative · entry 2 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2030-06-09 F3 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2021 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date. F4 · ownership.nature: This option was granted to Elisha P. Gould, a director of Corvus Pharmaceuticals, Inc., who is a partner of Adams Street Partners, LLC. Adams Street Partners, LLC is the managing member of the general partner of the general partner of each of the Funds. By agreement with the Funds, Mr. Gould is deemed to hold the option for the benefit of the Funds. The option may be deemed to be indirectly beneficially owned by Adams Street Partners, LLC. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), disclaim beneficial ownership of the option except to the extent of the pecuniary interest therein. Read SEC document
June 03, 2020 Filed Jun 5, 2020 20:05 UTC	Rimini Street, Inc. RMNI · Entity 5475	GrantRestricted Stock Unit · Derivative	38,167	$0.00	$0.00	Disclosure SEC source: 0001104659-20-070293 · tm2021940-1_4.xml · derivative · entry 11 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 38,167 Underlying: Common Stock · 38,167 shares Expires not disclosed F12 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting. F12 · shares: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting. F13 · derivative.exercise_date: 100% of the Restricted Stock Units awarded will vest on January 2, 2021, contingent upon Robin Murray's continued service as a member of the Issuer's Board of Directors through such date. F13 · derivative.expiration_date: 100% of the Restricted Stock Units awarded will vest on January 2, 2021, contingent upon Robin Murray's continued service as a member of the Issuer's Board of Directors through such date. F14 · ownership.nature: These Restricted Stock Units were granted to Robin Murray, a director of the Issuer, who is a partner of Adams Street Partners, LLC. Adams Street Partners, LLC is the managing member of the general partner of AS 2007, AS 2008 and AS 2009, the managing member of the general partner of the general partner of each of AS 2013, AS 2014, AS 2015, AS 2016 and AS VGVI, and the manager of ASRA. By agreement with the Funds, Mr. Murray is deemed to hold the Restricted Stock Units for the benefit of the Funds. F15 · ownership.nature: The Restricted Stock Units may be deemed to be indirectly beneficially owned by Adams Street Partners, LLC. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), disclaim beneficial ownership of the Restricted Stock Units except to the extent of their pecuniary interest therein. Read SEC document
March 31, 2020 Filed Apr 2, 2020 16:01 UTC	Aptinyx Inc. APTX · Entity 120922	GrantStock Option (Right to Buy) · Derivative	7,374	$1.36 Strike: $2.16	$9,999.14	Disclosure SEC source: 0001104659-20-042431 · tm2014861d1_4.xml · derivative · entry 1 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 7,374 Underlying: Common Stock · 7,374 shares Expires 2030-03-30 F1 · shares: The option award was issued to Elisha P. ("Terry") Gould III, who elected to take equity awards in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant. F2 · derivative.exercise_date: This option is fully vested at time of grant. F3 · ownership.nature: Elisha P. Gould III is a partner of Adams Street Partners, LLC ("Adams Street"). Adams Street is the direct or indirect general partner/investment adviser of managed entities that own common stock of the Issuer. By agreement with certain of such Adams Street funds, Mr. Gould is deemed to hold the stock options for the benefit of those funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin Murray and Fred Wang, each of whom is a partner of Adams Street (or a subsidiary thereof) may be deemed to have shared voting and investment power over the options. Adams Street and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin Murray and Fred Wang disclaim beneficial ownership of the options except to the extent of their pecuniary interest therein. Read SEC document
March 19, 2020 Filed Mar 23, 2020 20:03 UTC	Corvus Pharmaceuticals, Inc. CRVS · Entity 4839	GrantStock Option (Right to Buy) · Derivative	15,000	$0.00 Strike: $2.00	$0.00	Disclosure SEC source: 0001104659-20-037295 · tm2013500d1_4.xml · derivative · entry 2 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2030-03-19 F3 · derivative.exercise_date: 100% of the shares subject to the option vest and become exercisable on the one-year anniversary of the grant date, subject to continued service as a director through such date. F4 · ownership.nature: This option was granted to Elisha P. Gould, a director of Corvus Pharmaceuticals, Inc., who is a partner of Adams Street Partners, LLC. Adams Street Partners, LLC is the managing member of the general partner of the general partner of each of the Funds. By agreement with the Funds, Mr. Gould is deemed to hold the option for the benefit of the Funds. The option may be deemed to be indirectly beneficially owned by Adams Street Partners, LLC. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), disclaim beneficial ownership of the option except to the extent of the pecuniary interest therein. Read SEC document
January 29, 2020 Filed Feb 14, 2020 11:30 UTC	Aptinyx Inc. APTX · Entity 120922	OtherCommon Stock	90,124	$0.00	$0.00	Disclosure SEC source: 0001104659-20-021111 · tm207657d1_4.xml · nonDerivative · entry 1 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 185,120 F1 · shares: Represents 20,246 shares received by Adams Street Partnership Fund - 2002 U.S. Fund, L.P. (AS 2002 US), 18,583 shares received by Adams Street Partnership Fund - 2003 U.S. Fund, L.P. (AS 2003 US), 14,354 shares received by Adams Street Partnership Fund - 2004 U.S. Fund, L.P. (AS 2004 US), 19,995 shares received by Adams Street Partnership Fund - 2005 U.S. Fund, L.P. (AS 2005 US), 1,186 shares received by Brinson Partnership Fund - 2004 Primary Fund, L.P. (BPF 2004 Primary), 796 shares received by The 2004 Primary Brinson Partnership Fund Offshore Series Company Ltd. (BPF 2004 Offshore), 2,472 shares received by Brinson Partnership Fund Trust - 2004 Primary Fund (BPF 2004 Trust) and 12,492 shares received by The Bank of New York Mellon as Trustee for the HP Inc. Master Trust (HP Trust), in each case, for no consideration as part of an exempt pro-rata distribution of shares on January 29, 2020 by a fund controlled by a third-party manager. F2 · balance_after: Represents 41,587 shares held by AS 2002 US, 38,170 shares held by AS 2003 US, 29,484 shares held by AS 2004 US, 41,071 shares held by AS 2005 US, 2,436 shares held by BPF 2004 Primary, 1,635 shares held by BPF 2004 Offshore, 5,078 shares held by BPF 2004 Trust and 25,659 shares held by HP Trust. The foregoing totals reflect 21,341 shares received by AS 2002 US, 19,587 shares received by AS 2003 US, 15,130 shares received by AS 2004 US, 21,076 shares received by AS 2005 US, 1,250 shares received by BPF 2004 Primary, 839 shares received by BPF 2004 Offshore, 2,606 shares received by BPF 2004 Trust and 13,167 shares received by HP Trust, in each case, for no consideration as part of an exempt pro-rata distribution of shares on January 16, 2019 by a fund controlled by a third-party manager. F3 · ownership.nature: The shares owned by each of AS 2002 US, AS 2003 US, AS 2004 US, AS 2005 US, BPF 2004 Primary, BPF 2004 Offshore, BPF 2004 Trust and HP Trust (the aforementioned funds, the "Funds") may be deemed to be beneficially owned by Adams Street Partners, LLC, the general partner of AS 2002 US, AS 2003 US, AS 2004 US and AS 2005 US; which is the sub-advisor and acts under power of attorney with respect to BPF 2004 Primary, BPF 2004 Offshore and BPF 2004 Trust; and which is the advisor and acts under power of attorney with respect to HP Trust. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to share voting and dispositive power over the shares held by the Funds. F4 · ownership.nature: Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein. Read SEC document
January 10, 2020 Filed Jan 14, 2020 17:05 UTC	Aptinyx Inc. APTX · Entity 120922	PurchaseCommon Stock	349,806	$3.00	$1,049,418.00	Disclosure SEC source: 0001104659-20-003968 · tm203452d1_4.xml · nonDerivative · entry 6 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,465,716 F8 · shares: On January 10, 2020, AS 2012, AS 2013, AS 2014, AS 2015, AS 2016, and ASVG VI purchased 152,512, 115,367, 156,920, 120,453, 104,942, and 349,806 shares of common stock of the Issuer at a price of $3.00 per share, respectively, pursuant to an underwritten public offering. F6 · ownership.nature: The shares are held directly by Adams Street Venture/Growth Fund VI LP ("ASVG VI"). F7 · ownership.nature: Adams Street Partners, LLC is the managing member of the general partner of each of AS 2008, AS 2009, and AS 2010, and the managing member of the general partner of the general partner of AS 2011 (along with AS 2008, AS 2009 and AS 2010, as defined in footnote 9), AS 2012, AS 2013, AS 2014, AS 2015, AS 2016 and ASVG VI. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the reported shares. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang disclaim beneficial ownership of the shares held by each of the aforementioned funds except to the extent of their pecuniary interest therein. Read SEC document
January 10, 2020 Filed Jan 14, 2020 17:05 UTC	Aptinyx Inc. APTX · Entity 120922	PurchaseCommon Stock	104,942	$3.00	$314,826.00	Disclosure SEC source: 0001104659-20-003968 · tm203452d1_4.xml · nonDerivative · entry 5 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 439,714 F8 · shares: On January 10, 2020, AS 2012, AS 2013, AS 2014, AS 2015, AS 2016, and ASVG VI purchased 152,512, 115,367, 156,920, 120,453, 104,942, and 349,806 shares of common stock of the Issuer at a price of $3.00 per share, respectively, pursuant to an underwritten public offering. F5 · ownership.nature: The shares are held directly by Adams Street 2016 Direct Venture/Growth Fund LP ("AS 2016"). F7 · ownership.nature: Adams Street Partners, LLC is the managing member of the general partner of each of AS 2008, AS 2009, and AS 2010, and the managing member of the general partner of the general partner of AS 2011 (along with AS 2008, AS 2009 and AS 2010, as defined in footnote 9), AS 2012, AS 2013, AS 2014, AS 2015, AS 2016 and ASVG VI. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the reported shares. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang disclaim beneficial ownership of the shares held by each of the aforementioned funds except to the extent of their pecuniary interest therein. Read SEC document
January 10, 2020 Filed Jan 14, 2020 17:05 UTC	Aptinyx Inc. APTX · Entity 120922	PurchaseCommon Stock	120,453	$3.00	$361,359.00	Disclosure SEC source: 0001104659-20-003968 · tm203452d1_4.xml · nonDerivative · entry 4 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 504,708 F8 · shares: On January 10, 2020, AS 2012, AS 2013, AS 2014, AS 2015, AS 2016, and ASVG VI purchased 152,512, 115,367, 156,920, 120,453, 104,942, and 349,806 shares of common stock of the Issuer at a price of $3.00 per share, respectively, pursuant to an underwritten public offering. F4 · ownership.nature: The shares are held directly by Adams Street 2015 Direct Venture/Growth Fund LP ("AS 2015"). F7 · ownership.nature: Adams Street Partners, LLC is the managing member of the general partner of each of AS 2008, AS 2009, and AS 2010, and the managing member of the general partner of the general partner of AS 2011 (along with AS 2008, AS 2009 and AS 2010, as defined in footnote 9), AS 2012, AS 2013, AS 2014, AS 2015, AS 2016 and ASVG VI. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the reported shares. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang disclaim beneficial ownership of the shares held by each of the aforementioned funds except to the extent of their pecuniary interest therein. Read SEC document
January 10, 2020 Filed Jan 14, 2020 17:05 UTC	Aptinyx Inc. APTX · Entity 120922	PurchaseCommon Stock	156,920	$3.00	$470,760.00	Disclosure SEC source: 0001104659-20-003968 · tm203452d1_4.xml · nonDerivative · entry 3 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 711,151 F8 · shares: On January 10, 2020, AS 2012, AS 2013, AS 2014, AS 2015, AS 2016, and ASVG VI purchased 152,512, 115,367, 156,920, 120,453, 104,942, and 349,806 shares of common stock of the Issuer at a price of $3.00 per share, respectively, pursuant to an underwritten public offering. F3 · ownership.nature: The shares are held directly by Adams Street 2014 Direct Fund LP ("AS 2014"). F7 · ownership.nature: Adams Street Partners, LLC is the managing member of the general partner of each of AS 2008, AS 2009, and AS 2010, and the managing member of the general partner of the general partner of AS 2011 (along with AS 2008, AS 2009 and AS 2010, as defined in footnote 9), AS 2012, AS 2013, AS 2014, AS 2015, AS 2016 and ASVG VI. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the reported shares. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang disclaim beneficial ownership of the shares held by each of the aforementioned funds except to the extent of their pecuniary interest therein. Read SEC document
January 10, 2020 Filed Jan 14, 2020 17:05 UTC	Aptinyx Inc. APTX · Entity 120922	PurchaseCommon Stock	115,367	$3.00	$346,101.00	Disclosure SEC source: 0001104659-20-003968 · tm203452d1_4.xml · nonDerivative · entry 2 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 522,837 F8 · shares: On January 10, 2020, AS 2012, AS 2013, AS 2014, AS 2015, AS 2016, and ASVG VI purchased 152,512, 115,367, 156,920, 120,453, 104,942, and 349,806 shares of common stock of the Issuer at a price of $3.00 per share, respectively, pursuant to an underwritten public offering. F2 · ownership.nature: The shares are held directly by Adams Street 2013 Direct Fund LP ("AS 2013"). F7 · ownership.nature: Adams Street Partners, LLC is the managing member of the general partner of each of AS 2008, AS 2009, and AS 2010, and the managing member of the general partner of the general partner of AS 2011 (along with AS 2008, AS 2009 and AS 2010, as defined in footnote 9), AS 2012, AS 2013, AS 2014, AS 2015, AS 2016 and ASVG VI. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the reported shares. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang disclaim beneficial ownership of the shares held by each of the aforementioned funds except to the extent of their pecuniary interest therein. Read SEC document
January 10, 2020 Filed Jan 14, 2020 17:05 UTC	Aptinyx Inc. APTX · Entity 120922	PurchaseCommon Stock	152,512	$3.00	$457,536.00	Disclosure SEC source: 0001104659-20-003968 · tm203452d1_4.xml · nonDerivative · entry 1 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 691,176 F8 · shares: On January 10, 2020, AS 2012, AS 2013, AS 2014, AS 2015, AS 2016, and ASVG VI purchased 152,512, 115,367, 156,920, 120,453, 104,942, and 349,806 shares of common stock of the Issuer at a price of $3.00 per share, respectively, pursuant to an underwritten public offering. F1 · ownership.nature: The shares are held directly by Adams Street 2012 Direct Fund LP ("AS 2012"). F7 · ownership.nature: Adams Street Partners, LLC is the managing member of the general partner of each of AS 2008, AS 2009, and AS 2010, and the managing member of the general partner of the general partner of AS 2011 (along with AS 2008, AS 2009 and AS 2010, as defined in footnote 9), AS 2012, AS 2013, AS 2014, AS 2015, AS 2016 and ASVG VI. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the reported shares. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin P. Murray and Fred Wang disclaim beneficial ownership of the shares held by each of the aforementioned funds except to the extent of their pecuniary interest therein. Read SEC document
January 02, 2020 Filed Jan 6, 2020 21:03 UTC	Rimini Street, Inc. RMNI · Entity 5475	Exercise / conversionRestricted Stock Unit · Derivative	27,829	$0.00	$0.00	Disclosure SEC source: 0001104659-20-001507 · tm201291d1_4.xml · derivative · entry 11 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 27,829 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_price: On January 2, 2019, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 27,829 Restricted Stock Units which vested 100% on January 2, 2020. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting. F10 · shares: On January 2, 2019, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 27,829 Restricted Stock Units which vested 100% on January 2, 2020. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting. F10 · derivative.exercise_date: On January 2, 2019, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 27,829 Restricted Stock Units which vested 100% on January 2, 2020. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting. F10 · derivative.expiration_date: On January 2, 2019, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 27,829 Restricted Stock Units which vested 100% on January 2, 2020. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting. F13 · ownership.nature: These Restricted Stock Units were granted to Robin Murray, a director of the Issuer, who is a partner of Adams Street Partners, LLC. Adams Street Partners, LLC is the managing member of the general partner of AS 2007, AS 2008 and AS 2009, the managing member of the general partner of the general partner of each of AS 2013, AS 2014, AS 2015, AS 2016 and AS VGVI, and the manager of ASRA. By agreement with the Funds, Mr. Murray is deemed to hold the Restricted Stock Units for the benefit of the Funds. F14 · ownership.nature: The Restricted Stock Units may be deemed to be indirectly beneficially owned by Adams Street Partners, LLC. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang , each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), disclaim beneficial ownership of the Restricted Stock Units except to the extent of their pecuniary interest therein. Read SEC document
January 02, 2020 Filed Jan 6, 2020 21:03 UTC	Rimini Street, Inc. RMNI · Entity 5475	Exercise / conversionCommon Stock	27,829	Not disclosed	Not disclosed	Disclosure SEC source: 0001104659-20-001507 · tm201291d1_4.xml · nonDerivative · entry 10 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 39,456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · price: On January 2, 2019, Robin Murray, a director of the Issuer and partner of Adams Street Partners, LLC, was granted 27,829 Restricted Stock Units which vested 100% on January 2, 2020. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon vesting. F11 · ownership.nature: The shares of common stock were issued to Robin Murray, a director of the Issuer, who is a partner of Adams Street Partners, LLC. Adams Street Partners, LLC is the managing member of the general partner of AS 2007, AS 2008 and AS 2009, is the managing member of the general partner of the general partner of AS 2013, AS 2014, AS 2015, AS 2016 and AS VGVI (collectively, the "Funds") and is the manager of ASRA. By agreement with the Funds, Mr. Murray is deemed to hold the common stock for the benefit of the Funds. F12 · ownership.nature: The common stock may be deemed to be indirectly beneficially owned by Adams Street Partners, LLC. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), disclaim beneficial ownership of the common stock except to the extent of their pecuniary interest therein. Read SEC document
December 31, 2019 Filed Jan 3, 2020 16:01 UTC	Aptinyx Inc. APTX · Entity 120922	GrantStock Option (Right to Buy) · Derivative	4,668	$2.14 Strike: $3.42	$9,998.86	Disclosure SEC source: 0001104659-20-000840 · tm201092d1_4.xml · derivative · entry 1 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 4,668 Underlying: Common Stock · 4,668 shares Expires 2029-12-30 F1 · shares: The option award was issued to Elisha P. ("Terry") Gould III, who elected to take equity awards in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant. F2 · derivative.exercise_date: This option is fully vested at time of grant. F3 · ownership.nature: Elisha P. Gould III is a partner of Adams Street Partners, LLC ("Adams Street"). Adams Street is the direct or indirect general partner/investment adviser of managed entities that own common stock of the Issuer. By agreement with certain of such Adams Street funds, Mr. Gould is deemed to hold the stock options for the benefit of those funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin Murray and Fred Wang, each of whom is a partner of Adams Street (or a subsidiary thereof) may be deemed to have shared voting and investment power over the options. Adams Street and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin Murray and Fred Wang disclaim beneficial ownership of the options except to the extent of their pecuniary interest therein. Read SEC document
September 30, 2019 Filed Oct 2, 2019 16:01 UTC	Aptinyx Inc. APTX · Entity 120922	GrantStock Option (Right to Buy) · Derivative	4,802	$2.08 Strike: $3.49	$9,997.76	Disclosure SEC source: 0001144204-19-046946 · tv530461_4.xml · derivative · entry 1 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 4,802 Underlying: Common Stock · 4,802 shares Expires 2029-09-29 F1 · shares: The option award was issued to Elisha P. ("Terry") Gould III, who elected to take equity awards in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant. F2 · derivative.exercise_date: This option is fully vested at time of grant. F3 · ownership.nature: Elisha P. Gould III is a partner of Adams Street Partners, LLC ("Adams Street"). Adams Street is the direct or indirect general partner/investment adviser of managed entities that own common stock of the Issuer. By agreement with certain of such Adams Street funds, Mr. Gould is deemed to hold the stock options for the benefit of those funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin Murray and Fred Wang, each of whom is a partner of Adams Street (or a subsidiary thereof) may be deemed to have shared voting and investment power over the options. Adams Street and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin Murray and Fred Wang disclaim beneficial ownership of the options except to the extent of their pecuniary interest therein. Read SEC document
June 28, 2019 Filed Jul 2, 2019 16:01 UTC	Aptinyx Inc. APTX · Entity 120922	GrantStock Option (Right to Buy) · Derivative	5,046	$1.98 Strike: $3.34	$10,001.17	Disclosure SEC source: 0001144204-19-033569 · tv524685_4.xml · derivative · entry 1 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 5,046 Underlying: Common Stock · 5,046 shares Expires 2029-06-27 F1 · shares: The option award was issued to Elisha P. ("Terry") Gould III, who elected to take equity awards in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant. F2 · derivative.exercise_date: This option is fully vested at time of grant. F3 · ownership.nature: Elisha P. Gould III is a partner of Adams Street Partners, LLC ("Adams Street"). Adams Street is the direct or indirect general partner/investment adviser of managed entities that own common stock of the Issuer. By agreement with certain of such Adams Street funds, Mr. Gould is deemed to hold the stock options for the benefit of those funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin Murray and Fred Wang, each of whom is a partner of Adams Street (or a subsidiary thereof) may be deemed to have shared voting and investment power over the options. Adams Street and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould III, Robin Murray and Fred Wang disclaim beneficial ownership of the options except to the extent of their pecuniary interest therein. Read SEC document
June 20, 2019 Filed Jun 21, 2019 20:10 UTC	Rimini Street, Inc. RMNI · Entity 5475	OtherCommon Stock	3,487	Not disclosed	Not disclosed	Disclosure SEC source: 0001144204-19-031884 · tv523994_4.xml · nonDerivative · entry 9 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 300,514 F1 · price: On June 20, 2019, in exchange for receiving the written consent of the original holders of its 13.00% Series A Redeemable Convertible Preferred Stock (the "Series A Preferred Stock") to engage in the sale and issuance of securities on terms that are substantively the same as to all existing holders of the Series A Preferred Stock, the Issuer issued shares of its Common Stock to each such original holder. For additional information, see the Issuer's Current Report on Form 8-K filed with the SEC on June 21, 2019. F10 · ownership.nature: Represents shares held directly by Adams Street Rimini Aggregator LLC ("ASRA"). Adams Street Partners, LLC, as the manager of ASRA, may be deemed to beneficially own the shares held by ASRA. David Brett, Elisha P. Gould, Sachin Tulyani and Craig D. Waslin, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by ASRA. Adams Street Partners, LLC and David Brett, Elisha P. Gould, Sachin Tulyani and Craig D. Waslin disclaim beneficial ownership of the shares held by ASRA except to the extent of their pecuniary interest therein. Read SEC document
June 20, 2019 Filed Jun 21, 2019 20:10 UTC	Rimini Street, Inc. RMNI · Entity 5475	OtherCommon Stock	417	Not disclosed	Not disclosed	Disclosure SEC source: 0001144204-19-031884 · tv523994_4.xml · nonDerivative · entry 3 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 4,307,978 F1 · price: On June 20, 2019, in exchange for receiving the written consent of the original holders of its 13.00% Series A Redeemable Convertible Preferred Stock (the "Series A Preferred Stock") to engage in the sale and issuance of securities on terms that are substantively the same as to all existing holders of the Series A Preferred Stock, the Issuer issued shares of its Common Stock to each such original holder. For additional information, see the Issuer's Current Report on Form 8-K filed with the SEC on June 21, 2019. F4 · ownership.nature: Represents shares held directly by Adams Street 2009 Direct Fund, L.P. ("AS 2009"). Adams Street Partners, LLC, as the managing member of the general partner of AS 2009, may be deemed to beneficially own the shares held by AS 2009. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by AS 2009. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, and Fred Wang disclaim beneficial ownership of the shares held by AS 2009 except to the extent of their pecuniary interest therein. Read SEC document
June 20, 2019 Filed Jun 21, 2019 20:10 UTC	Rimini Street, Inc. RMNI · Entity 5475	OtherCommon Stock	476	Not disclosed	Not disclosed	Disclosure SEC source: 0001144204-19-031884 · tv523994_4.xml · nonDerivative · entry 2 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 4,916,957 F1 · price: On June 20, 2019, in exchange for receiving the written consent of the original holders of its 13.00% Series A Redeemable Convertible Preferred Stock (the "Series A Preferred Stock") to engage in the sale and issuance of securities on terms that are substantively the same as to all existing holders of the Series A Preferred Stock, the Issuer issued shares of its Common Stock to each such original holder. For additional information, see the Issuer's Current Report on Form 8-K filed with the SEC on June 21, 2019. F3 · ownership.nature: Represents shares held directly by Adams Street 2008 Direct Fund, L.P. ("AS 2008"). Adams Street Partners, LLC, as the managing member of the general partner of AS 2008, may be deemed to beneficially own the shares held by AS 2008. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by AS 2008. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, and Fred Wang disclaim beneficial ownership of the shares held by AS 2008 except to the extent of their pecuniary interest therein. Read SEC document
June 20, 2019 Filed Jun 21, 2019 20:10 UTC	Rimini Street, Inc. RMNI · Entity 5475	OtherCommon Stock	422	Not disclosed	Not disclosed	Disclosure SEC source: 0001144204-19-031884 · tv523994_4.xml · nonDerivative · entry 1 ADAMS STREET PARTNERS LLC · CIK 0001193586 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 4,362,212 F1 · price: On June 20, 2019, in exchange for receiving the written consent of the original holders of its 13.00% Series A Redeemable Convertible Preferred Stock (the "Series A Preferred Stock") to engage in the sale and issuance of securities on terms that are substantively the same as to all existing holders of the Series A Preferred Stock, the Issuer issued shares of its Common Stock to each such original holder. For additional information, see the Issuer's Current Report on Form 8-K filed with the SEC on June 21, 2019. F2 · ownership.nature: Represents shares held directly by Adams Street 2007 Direct Fund, L.P. ("AS 2007"). Adams Street Partners, LLC, as the managing member of the general partner of AS 2007, may be deemed to beneficially own the shares held by AS 2007. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by AS 2007. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, and Fred Wang disclaim beneficial ownership of the shares held by AS 2007 except to the extent of their pecuniary interest therein. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.